Financial report interval: 2025.12.31 - 2026.03.31
Overview: FENGYUAN PHARMACEUTICAL(000153) the Revenue is 835.92 M (-11.14%);the EBIT is 50.84 M (-11.07%);the EPS is 0.0796 (-2.69%).